EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value

Manolo D'Arcangelo, Federico Cappuzzo

ISRN Molecular Biology · 2012

DOI: 10.5402/2012/837306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ISRN Molecular Biology, 2012. Verfasst von Manolo D'Arcangelo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Toscano Tumori, Ospedale Civile di Livorno, 57100 Livorno, Italy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Italian Association for Cancer Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small-cell lung cancer (NSCLC) is a heterogeneous disease due to the presence of different clinically relevant molecular subtypes. Until today, several biological events have been identified in lung adenocarcinoma, including epidermal growth factor receptor ( EGFR ) mutations and anaplastic lymphoma kinase ( ALK ) translocations, offering new hopes to patients with metastatic disease. Unfortunately, in approximately 50% of adenocarcinoma and for those harbouring K-RAS mutations, the most frequent mutation in Caucasian lung adenocarcinoma, so far no specific drug demonstrated efficacy. The rat sarcoma ( RAS ) genes, including H-RAS, K-RAS, and N-RAS , encode a family of proteins regulating cell growth, differentiation, and apoptosis. K-RAS mutations are present in 20–30% of NSCLC and occur most commonly, but not exclusively, in adenocarcinoma histology and life-long smokers. Although in colorectal cancer patients K-RAS mutations represent a validated negative predictive biomarker for treatment with anti-EGFR monoclonal antibodies, their role in selecting specific treatment for NSCLC patients remains undefined. Aim of the present paper is to critically analyze the prognostic and predictive value of K-RAS mutations in NSCLC.

Autor:innen und Institutionen

  • Istituto Toscano Tumori, Ospedale Civile di Livorno, 57100 Livorno, Italy.

Förderung

  • Italian Association for Cancer Research

Zitieren

APA

D'Arcangelo, M., & Cappuzzo, F. (2012). K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value. ISRN Molecular Biology. https://doi.org/10.5402/2012/837306

Vancouver

D'Arcangelo M, Cappuzzo F. K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value. ISRN Molecular Biology. 2012. doi:10.5402/2012/837306

BibTeX
@article{DArcangelo2012,
  author = {D'Arcangelo, Manolo and Cappuzzo, Federico},
  title = {K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value},
  journal = {ISRN Molecular Biology},
  year = {2012},
  doi = {10.5402/2012/837306}
}
Kostenlos starten →